The goal of this activity is to improve pharmacists’ knowledge and confidence regarding the evidence-based management of ankylosing spondylitis.
Upon completion of this program, participants should be better able to:
1. Apply current evidence-based guidelines to the effective use of biologic therapies in patients with ankylosing spondylitis.
2. Incorporate prescribing information for biologic therapies into the management of ankylosing spondylitis.
3. Discuss recent safety and efficacy outcomes from clinical trials and real-world studies on the use of anti-IL-17A antibodies in patients with ankylosing spondylitis.
This accredited activity has been designed for pharmacists.